TELUS flags significant regulatory risks in Québecor takeover proposal
TU•TELUS says it is still reviewing Québecor’s proposal and strategic alternatives, with no decision on a transaction. The November 9 proposal includes TELUS Health and raises the exchange ratio to 0.17 Québecor shares per TELUS share, but TELUS’s board considers the offer inadequate.
1. Board cites risks
TELUS said it continues to review Québecor’s acquisition proposal and strategic alternatives, but has made no decision on whether to pursue a transaction. The November 9, 2026 proposal includes TELUS Health and increases the exchange ratio from 0.16 to 0.17 Québecor shares per TELUS share. TELUS’s board considers the offer inadequate, citing significant regulatory uncertainty and insufficient compensation for transaction risks.
2. Control and leverage
TELUS said Québecor’s controlling shareholder would gain voting control despite contributing a minority of the combined company’s economic value. Under Québecor’s assumptions, combined net leverage would be approximately 4.1 times estimated 2027 EBITDA, potentially limiting investment capacity.




